FDA.reportPublic FDA data

BX Rating tacrolimus 5 MG Oral Capsule

RxCUI
2665163
RxNorm name
BX Rating tacrolimus 5 MG Oral Capsule
Display name
BX Rating tacrolimus 5 MG Oral Capsule
Full name
BX Rating tacrolimus 5 MG Oral Capsule
Term type
SCD
Status
DailyMed mapping
Updated
2026-06-04 23:39:18

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
TacrolimusTACROLIMUSAccord Healthcare Inc.bd447ffa-9196-4c3c-accf-5adf29b846652025-06-02Boxed warning, Warnings, Adverse reactionsExact identifier
rxcui: 2665163

DailyMed RxNorm Mappings#

unique DailyMed labels mapped to this RxNorm concept page 1 of 1 · 1 matching rows.

Set ID, RxNorm mappings, Terms table
Set IDRxNorm mappingsTermsSPL versionLabelEffective
bd447ffa-9196-4c3c-accf-5adf29b84665tacrolimus 5 MG Oral Capsule, BX Rating [PSN] · BX Rating tacrolimus 5 MG Oral Capsule [SCD] · tacrolimus 5 MG Oral Capsule, BX Rating [SY]316These highlights do not include all the information needed to use TACROLIMUS CAPSULES safely and effectively. See full prescribing information for TACROLIMUS CAPSULES. TACROLIMUS capsules, for oral use Initial U.S. Approval: 199420250602